ALKBH5 and neoplasm: HSPA4 overexpression upregulates ALKBH5 via increasing its protein stability, leading to decrease of CD58 of tumor cells and increase of PD1/PDL1 axis, finally to impair the toxicity of CD8+ T cells and immune evasion of GC cells.